We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Pharmacy Expenditures for Children With Serious Chronic Illness—Reply

Lisa J. Chamberlain, MD, MPH1; Sonja M. Swenson, BA2; Paul H. Wise, MD, MPH1
[+] Author Affiliations
1Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California
2Center for Health Policy and Center for Primary Care and Outcomes Research, Stanford University, Stanford, California
JAMA. 2016;315(7):706-707. doi:10.1001/jama.2015.16981.
Text Size: A A A
Published online


In Reply We agree with Drs Ruble and Brixner that not all patients with hemophilia are the same. These patients represent a wide range of severity, and the cost skewing within the group reflects that. Hemophilia is not unique in this—most serious pediatric conditions demonstrate a range in severity.

Ruble and Brixner accurately describe the reasons for this variation, including presence of inhibitors, and note that patients with inhibitors have higher costs of therapy.1 We do not dispute these facts. Our Research Letter was not meant to be a profile of patients with hemophilia in California, but an analysis of overall outpatient pharmacy expenditures by children with serious chronic illness.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




February 16, 2016
James H. Ruble, PharmD, JD; Diana I. Brixner, RPh, PhD
1Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City
JAMA. 2016;315(7):706. doi:10.1001/jama.2015.16978.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...